comparemela.com

Page 4 - நோயியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2021 Jack Scoble Scholarships Awarded

Report reveals 72,500 rural and remote Australians admitted to hospital each year due to medicine-related problems

Date Time Share Report reveals 72,500 rural and remote Australians admitted to hospital each year due to medicine-related problems Pharmaceutical Society of Australia A new report has revealed 1.3 million rural and remote Australians do not take their medicines at all or as intended adding an estimated $2.03 billion to our annual health care costs. The Medicine Safety: Rural and remote care report, developed for the Pharmaceutical Society of Australia by Charles Sturt University, also found that 72,500 rural and remote Australians are admitted to hospital each year due to problems with their medicines, costing the health care system $400 million. The report will be launched by NSW Health Minister Brad Hazzard in Sydney on Saturday 13 March.

Whole genome sequencing may guide blood cancer treatment

Whole genome sequencing may guide blood cancer treatment For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes. Some of these tests rely on technology that was invented more than 60 years ago and has been used clinically for the past three decades. Now, a new study from Washington University School of Medicine in St. Louis shows that whole genome sequencing is at least as accurate and often better than conventional genetic tests that help determine the treatment for a patient s blood cancer. Genome sequencing technology continuously is decreasing in cost and recently reached a level similar to that of conventional testing. In addition, results can be returned to patients in just a few days, making whole genome sequencing a potentially viable approach for determining the best treatment regimen for a particular patien

Early Release - Intersecting Paths of Emerging and Reemerging Infectious Diseases - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal

  Author affiliations: Universidade de Brasília, Brasília, Brazil (T.M. Wilson); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (T.M. Wilson, C.D. Paddock, S. Reagan-Steiner, J. Bhatnagar, R.B. Martines, H. Venkat, S.R. Zaki); Pinal County Office of the Medical Examiner, Florence, Arizona, USA (A.L. Wiens); Coconino County Health and Human Services Medical Examiner’s Office, Flagstaff, Arizona, USA (M. Madsen); Arizona Department of Health Services, Phoenix, Arizona, USA (K.K. Komatsu, H. Venkat) Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shares common clinicopathologic features with other severe pulmonary illnesses. Hantavirus pulmonary syndrome was diagnosed in 2 patients in Arizona, USA, suspected of dying from infection with SARS-CoV-2. Differential diagnoses and possible co-infections should be considered for cases of respiratory distress during the SARS-CoV-2 pandemic.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.